Abstract

As a first host barrier, the skin is constantly exposed to environmental insults that perturb its integrity. Tight regulation of skin homeostasis is largely controlled by the aryl hydrocarbon receptor (AhR). Here, we demonstrate that Henna and its major pigment, the naphthoquinone Lawsone activate AhR, both in vitro and in vivo. In human keratinocytes and epidermis equivalents, Lawsone exposure enhances the production of late epidermal proteins, impacts keratinocyte differentiation and proliferation, and regulates skin inflammation. To determine the potential use of Lawsone for therapeutic application, we harnessed human, murine and zebrafish models. In skin regeneration models, Lawsone interferes with physiological tissue regeneration and inhibits wound healing. Conversely, in a human acute dermatitis model, topical application of a Lawsone-containing cream ameliorates skin irritation. Altogether, our study reveals how a widely used natural plant pigment is sensed by the host receptor AhR, and how the physiopathological context determines beneficial and detrimental outcomes.

Details

Title
The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis
Author
Lozza, Laura 1 ; Moura-Alves, Pedro 2   VIAFID ORCID Logo  ; Domaszewska Teresa 1 ; Lage Crespo Carolina 3 ; Streata Ioana 4 ; Kreuchwig Annika 5 ; Puyskens Andreas 1 ; Bechtle Marina 1 ; Klemm, Marion 1 ; Zedler Ulrike 1 ; Silviu Ungureanu Bogdan 6 ; Guhlich-Bornhof Ute 1 ; Koehler Anne-Britta 1 ; Stäber Manuela 1 ; Mollenkopf Hans-Joachim 7   VIAFID ORCID Logo  ; Hurwitz, Robert 8 ; Furkert Jens 5 ; Krause, Gerd 5 ; Weiner January 3rd 1 ; Jacinto António 3 ; Mihai Ioana 4 ; Leite-de-Moraes, Maria 9   VIAFID ORCID Logo  ; Siebenhaar, Frank 10 ; Maurer, Marcus 10 ; Kaufmann Stefan H E 11   VIAFID ORCID Logo 

 Max Planck Institute for Infection Biology, Charitéplatz 1, Department of Immunology, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699) 
 Max Planck Institute for Infection Biology, Charitéplatz 1, Department of Immunology, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699); University of Oxford, Nuffield Department of Clinical Medicine, Ludwig Institute for Cancer Research, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 NOVA University of Lisbon, CEDOC, NOVA Medical School, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713) 
 Human Genomics Laboratory - University of Medicine and Pharmacy of Craiova, Craiova, Romania (GRID:grid.413055.6) (ISNI:0000 0004 0384 6757) 
 Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, Berlin, Germany (GRID:grid.418832.4) (ISNI:0000 0001 0610 524X) 
 University of Medicine and Pharmacy of Craiova, Research Center of Gastroenterology and Hepatology, Craiova, Romania (GRID:grid.413055.6) (ISNI:0000 0004 0384 6757) 
 Max Planck Institute for Infection Biology, Charitéplatz 1, Microarray Core Facility, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699) 
 Max Planck Institute for Infection Biology. Charitéplatz 1, Biochemistry and Protein Purification Core Facility, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699) 
 INEM (Institut Necker-Enfants Malades), CNRS UMR8253, INSERM UMR1151 and Paris Descartes University, Laboratory of Immunoregulation and Immunopathology, Paris, France (GRID:grid.10992.33) (ISNI:0000 0001 2188 0914) 
10  Charité-Universitätsmedizin Berlin, Department of Dermatology and Allergy, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662) 
11  Max Planck Institute for Infection Biology, Charitéplatz 1, Department of Immunology, Berlin, Germany (GRID:grid.418159.0) (ISNI:0000 0004 0491 2699); Texas A&M University, Hagler Institute for Advanced Study, College Station, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2264592165
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.